Our vision

About one in 50 men and women will be diagnosed with lymphoma in their lifetime. In the Netherlands alone, approximately 4,000 new patients are added each year and this number is increasing. This makes lymphoma the 3rd cancer in children and adolescents and the 5th cancer in adults.

Despite intensive treatments, more than 1,000 patients die each year in the Netherlands as a result of this disease. There is still too little attention for lymphoma and there are still insufficient good treatment options.

Lymph&Co aims to draw attention to lymphoma and to finance groundbreaking scientific research into better and more effective treatments.